Asian PX prices rise to 8-year high
Recently, data released by S&P Global Commodity Insights showed that on June 7, Asian paraxylene (PX) prices surged to the highest level in 8 years, driven by tight supply, the opening of the Asia-US arbitrage window and strong demand, while profit margins. Improved to the best level in more than 3 years.
Data show that on June 7, the price of paraxylene in China soared by US$65.83/ton (cost plus freight, CFR), rising by US$194.16/ton to US$1,484.33/ton week-on-week, the highest level since July 2014. Standard & Poor's said that the price of PX has risen faster than the raw material naphtha, and it is also the first time in more than three years that it has exceeded the US$600/ton level. Usually, the price difference between the two is maintained at US$220-280/ton to break even. The rise in Asian PX prices is due to an upward trend in the Asian aromatics market due to the opening of the arbitrage window between Asia and the United States and strong demand for gasoline blending components.
S&P Global Commodity Insights said that while the U.S. PX market has largely stagnated, lower productivity and tight supply of raw materials have prompted participants to seek PX imports from Asia since April. The trend continued in May, given the sharp drop in U.S. aromatics production, the report said. In Asia, U.S. dollar-denominated PX supplies have tightened further since May as some major producers plan overhauls, S&P said, with PX supplies tight since May, while refinery side PX producers prioritized producing gasoline over aromatics. . Prices will remain stable in July and supply is expected to resume in August when multiple units are overhauled, multiple sources said. Good profit margins for PX producers in mainland China may push up run rates.
2026-08-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
-
Henkel’s €60 Million Adhesive Technologies Inspiration Center in Shanghai Goes into Operation, Aiming to Build an R&D Hub for Asia-Pacific
-
Marinela Makeup Partners with FasterCapital to Scale Its Vegan Beauty Line
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
Dow × Hisense’s Innovation Code: A Deep Game of Sustainability
-
Hormuz Crisis Pushes Up Urea Prices as Yara’s Quarterly EBITDA Jumps 39%
-
“The C Empire Unites!”: Wanhua Chemical’s $26.5 Billion Bet on Ethylene Integration—Is It Becoming China’s BASF or the New Global Olefins Overlord?
Recommend Reading
-
“An €8 Billion Loss, Yet a 25% Price Hike”: Wacker Chemie’s Contradictory Crisis—Survival Move or Desperate Gamble?
-
BASF's Zhanjiang Plant Steam Cracking Unit Commences Operation
-
Givaudan Introduces New Labdanum Absolute for Fragrance Creations
-
Evonik to Spin Off Infrastructure Operations into New Services Company SYNEQT
-
Borealis Commits Over €100 Million to New PP Compounds Line in Austria
-
Cost Support Boosts Acrylic Acid, High-level Supply and Demand Stalemate Leads to Sideways Movement
-
Intensifying Long and Short Positions in Lithium Carbonate, Market Trends Downward
-
China's SBR Prices Rise Driven by Costs
-
This week, the coke market in China was mainly weak.
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
- Hot Searches
- boron trifluorid
- potassium sulfide
- where can i buy tirzepatide in bulk
- boric acide
- anhydrous ammonia suppliers near me
- sodium lignosulfonate price
- retatrutide supplier china
- triz peptide
- anadrol for sale
- sodium metasilicate pentahydrate
- dapagliflozin 5 mg tablet
- methyl ethyl ketone for sale